thiazoles has been researched along with Uterine Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, K; Jiang, J; Liu, Z; Lu, W; Ma, X; Qiu, C; Wei, L; Yan, H; Zhao, T | 1 |
| Patrono, D; Rendina, GM | 1 |
1 trial(s) available for thiazoles and Uterine Diseases
| Article | Year |
|---|---|
[New synthetic preparation (2-phenyl-4-parachlorophenyl-thiazol-5-hylacetic acid) for pelvic inflammations of gynecologic interest].
Topics: Anti-Inflammatory Agents; Chlorobenzenes; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Pelvic Inflammatory Disease; Thiazoles; Uterine Diseases | 1974 |
1 other study(ies) available for thiazoles and Uterine Diseases
| Article | Year |
|---|---|
Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma.
Topics: Endometrial Neoplasms; Endometrium; Female; Humans; NF-kappa B; Pyridines; Regulatory Elements, Transcriptional; Sterol Regulatory Element Binding Protein 1; Thiazoles; Transfection; Uterine Diseases | 2021 |